On June 22, 2023, Board of Directors of Regulus Therapeutics Inc. appointed Preston S. Klassen, M.D., President and Head of Research & Development, to the Board, to serve until next annual meeting of stockholders and until his successors is duly elected and qualified, or until his earlier death, resignation or removal.